Filter News
Area of Research
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (4)
- (-) Climate Change (1)
- (-) Transportation (2)
- 3-D Printing/Advanced Manufacturing (3)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (3)
- Biology (4)
- Biotechnology (1)
- Composites (1)
- Computer Science (6)
- Coronavirus (5)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (2)
- Environment (4)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (1)
- Materials (6)
- Materials Science (13)
- Microscopy (1)
- Nanotechnology (7)
- National Security (1)
- Neutron Science (43)
- Nuclear Energy (1)
- Physics (7)
- Quantum Science (5)
- Security (1)
- Space Exploration (1)
- Summit (4)
- Sustainable Energy (2)
Media Contacts
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
In the quest for advanced vehicles with higher energy efficiency and ultra-low emissions, ORNL researchers are accelerating a research engine that gives scientists and engineers an unprecedented view inside the atomic-level workings of combustion engines in real time.
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
The Department of Energy’s Office of Science has selected three Oak Ridge National Laboratory scientists for Early Career Research Program awards.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
Researchers used neutrons to probe a running engine at ORNL’s Spallation Neutron Source